{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Parsippany",
      "address_1": "400 Interpace Pkwy",
      "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.",
      "address_2": "",
      "product_quantity": "2,924,000 tablets",
      "code_info": "Arrow Malta (Teva) Bulk Product Lot #  1169752A, exp. date 01/2020, 1000 tablets/bottle  1169753A, exp. date 01/2020, 90 tablets/bottle    Golden State Medical Finished Product Lot #  GS017387, exp. date 01/2020  GS017651, exp. date 01/2020  GS017479, exp. date 01/2020",
      "center_classification_date": "20190709",
      "distribution_pattern": "Nationwide by 4 major distributors.",
      "state": "NJ",
      "product_description": "LOSARTAN POTASSIUM 50 mg TABLET BULK  90 count bottles and 1000 count bottles, NDC 00591-3746-00",
      "report_date": "20190717",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva Pharmaceuticals USA",
      "recall_number": "D-1455-2019",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "83050",
      "more_code_info": "",
      "recall_initiation_date": "20190606",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Ongoing"
    }
  ]
}